DDAVP injection and Insulin glargine, recombinant Subcutaneous
Determining the interaction of DDAVP injection and Insulin glargine, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: desmopressin
Brand name: DDAVP, Nocdurna, DDAVP nasal, DDAVP Rhinal Tube, Noctiva, Stimate
Synonyms: DDAVP (injection), DDAVP
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- DDAVP injection-Insulin glulisine
- DDAVP injection-Insulin Glulisine (Cartridges and Pens)
- DDAVP injection-Insulin Glulisine (Vials)
- DDAVP injection-Insulin glulisine Subcutaneous
- DDAVP injection-Insulin human inhaled Inhalation
- DDAVP injection-Insulin human regular Injection
- Insulin glargine, recombinant Subcutaneous-DDAVP nasal
- Insulin glargine, recombinant Subcutaneous-DDAVP Nasal Spray
- Insulin glargine, recombinant Subcutaneous-DDAVP Oral
- Insulin glargine, recombinant Subcutaneous-DDAVP Rhinal Tube
- Insulin glargine, recombinant Subcutaneous-DDAVP Rhinal Tube nasal
- Insulin glargine, recombinant Subcutaneous-DDAVP Tablets